Clinical trial screening questions for seniors and families in Los Angeles. Educational navigation only; study details must be confirmed by the research team.
Potential Compensation
Study Duration
Study Location
Kidney research may evaluate monitoring tools, blood pressure support, diabetes-related kidney protection, medication approaches, education, or ways to slow kidney function decline in people with chronic kidney disease risk or diagnosis.
All Seniors Foundation can help you ask about current screening and prepare practical questions before speaking with a research team. A screening inquiry does not guarantee enrollment, treatment, payment, or medical benefit. Final eligibility, study availability, visit requirements, risks, possible benefits, and any compensation must be confirmed by the study team during formal screening and informed consent.
A coordinator may ask about kidney function labs, urine protein, diabetes, blood pressure, heart disease, medications, kidney specialist visits, dialysis status, swelling, fatigue, and family history. Some studies may include blood tests, urine tests, medication review, questionnaires, or follow-up visits.
The research team should explain the study purpose, what is optional or required, how personal information is protected, whether your regular clinician should be involved, and what choices you have before signing any consent document.
Before you call, gather recent creatinine, eGFR, urine albumin, A1C, blood pressure, and medication information if you have it. Write down whether you see a nephrologist, have diabetes or heart disease, or have been told your kidney numbers are changing.
Helpful preparation makes the first conversation more productive. You can also write down transportation needs, caregiver availability, preferred call times, language needs, and any questions your family or clinician wants answered before you continue.
After a screening call, ask how lab results are reviewed, whether your kidney doctor should be involved, what happens if abnormal labs appear, and whether the study includes medicine changes, lifestyle support, or monitoring only.
If the study is not a fit, ask whether there are other research options, educational resources, or follow-up questions you should discuss with your personal healthcare provider.
We can help you organize questions, prepare a medication list, identify records that may be useful, and understand what to ask before deciding whether a study is right for you. We encourage seniors and families to involve the senior’s primary doctor or specialist before making decisions about research participation.
For general research education, review the ClinicalTrials.gov guide to clinical studies and NIH Clinical Research Trials and You. For condition background, review NIDDK information about chronic kidney disease testing.
Call All Seniors Foundation or submit the screening inquiry form to ask whether chronic kidney disease research screening is currently available. You can ask questions first and decide later whether to continue with formal screening.
A screening call helps you understand the study, possible time commitment, informed consent process, and whether the research team may be a fit for your situation.
Some studies may provide compensation for completed study visits, travel, or time, depending on the protocol and eligibility.
Study-related visits are reviewed by trained research staff, with screening steps designed to protect participant safety.
Volunteers help researchers answer important health questions that may improve care options in the future.
A coordinator can explain what is required before you decide whether to continue with formal screening.
You can ask questions about visits, risks, possible benefits, privacy, and what participation would involve.
Participation is voluntary, and the research team should explain consent, withdrawal, and next steps before enrollment.
These points are only a starting guide. Final eligibility, availability, and enrollment decisions are confirmed by the study team.
Study openings, screening windows, and eligibility requirements can change.
No-obligation inquiry. Participation is voluntary and depends on formal screening.
Get answers to common questions before deciding whether to ask about formal screening
No. A screening inquiry is only the first step. The study team confirms eligibility, availability, requirements, risks, possible benefits, and any compensation before enrollment.
The team may ask about chronic kidney disease, current symptoms, medications, medical history, recent test results, and whether study visits or follow-up tasks are realistic.
Depending on the protocol, screening may include blood work, urine testing, medication review, blood pressure checks, questionnaires, or kidney-function monitoring. The research team should explain each step before you decide whether to continue.
Not necessarily. Some studies include randomization, placebo controls, monitoring only, or comparison groups. The informed consent process should explain how assignment works.
Yes. Research participation is voluntary. Consent materials should explain how withdrawal works and who to contact with questions or concerns.
Clinical research should be reviewed, explained clearly, and built around informed consent, privacy, and participant choice.
Drug and device studies may follow applicable FDA and research oversight requirements.
Institutional review boards help evaluate participant protections and informed consent materials.
The study team should explain how personal and health information is collected, used, and protected.
You can ask questions, review consent materials, and decide whether participation is right for you.
Contact All Seniors Foundation to ask whether screening is available and what questions to prepare before speaking with the study team.
(818) 581-4101
Available 8 AM - 6 PM, Mon-Sun
16101 Ventura Blvd Suite 300
Encino, CA 91436
